1. Home
  2. CPK vs CGON Comparison

CPK vs CGON Comparison

Compare CPK & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPK
  • CGON
  • Stock Information
  • Founded
  • CPK 1990
  • CGON 2010
  • Country
  • CPK United States
  • CGON United States
  • Employees
  • CPK N/A
  • CGON 61
  • Industry
  • CPK Oil & Gas Production
  • CGON
  • Sector
  • CPK Utilities
  • CGON
  • Exchange
  • CPK Nasdaq
  • CGON NYSE
  • Market Cap
  • CPK 2.7B
  • CGON 2.2B
  • IPO Year
  • CPK N/A
  • CGON 2024
  • Fundamental
  • Price
  • CPK $127.07
  • CGON $32.84
  • Analyst Decision
  • CPK Hold
  • CGON Strong Buy
  • Analyst Count
  • CPK 3
  • CGON 8
  • Target Price
  • CPK $121.00
  • CGON $63.88
  • AVG Volume (30 Days)
  • CPK 92.0K
  • CGON 396.6K
  • Earning Date
  • CPK 11-07-2024
  • CGON 11-12-2024
  • Dividend Yield
  • CPK 2.02%
  • CGON N/A
  • EPS Growth
  • CPK N/A
  • CGON N/A
  • EPS
  • CPK 4.91
  • CGON N/A
  • Revenue
  • CPK $757,489,000.00
  • CGON $684,000.00
  • Revenue This Year
  • CPK $24.70
  • CGON $411.76
  • Revenue Next Year
  • CPK $6.89
  • CGON $405.27
  • P/E Ratio
  • CPK $25.87
  • CGON N/A
  • Revenue Growth
  • CPK 12.63
  • CGON 258.12
  • 52 Week Low
  • CPK $90.22
  • CGON $25.77
  • 52 Week High
  • CPK $128.81
  • CGON $50.23
  • Technical
  • Relative Strength Index (RSI)
  • CPK 61.18
  • CGON 41.08
  • Support Level
  • CPK $121.00
  • CGON $35.12
  • Resistance Level
  • CPK $128.81
  • CGON $40.47
  • Average True Range (ATR)
  • CPK 2.70
  • CGON 1.69
  • MACD
  • CPK 0.62
  • CGON -0.28
  • Stochastic Oscillator
  • CPK 77.17
  • CGON 4.57

About CPK Chesapeake Utilities Corporation

Chesapeake Utilities Corp is a diversified energy delivery company that is engaged in natural gas transmission and distribution, electricity generation and distribution, propane gas distribution, mobile compressed natural gas utility services and solutions and other businesses. The company operates in two reportable segments, Regulated Energy and Unregulated Energy. The company's natural gas and electric distribution operations in Delaware, Maryland and Florida are subject to regulation by their respective PSC. Eastern Shore, its natural gas transmission subsidiary, is subject to regulation by the FERC and Peninsula Pipeline and Aspire Energy Express, its intrastate pipeline subsidiaries, are subject to regulation by the Florida PSC and Public Utilities Commission of Ohio, respectively.

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Share on Social Networks: